SCHEMBL5824570

SCHEMBL5824570

O=C(Cc1ccccc1Cl)N=C=S

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTBP2 P56545 1/20 0.50
PKM P14618 1/20 0.49
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
KCNJ5 P48544 2/20 0.41
KCNJ3 P48549 2/20 0.41
KMT2A Q03164 2/20 0.40
SHBG P04278 1/20 0.40
APAF1 O14727 1/20 0.40
TDP2 O95551 1/20 0.40
NSD2 O96028 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
SAE1 Q9UBE0 1/20 0.40
UBA2 Q9UBT2 1/20 0.40
ERCC1 P07992 1/20 0.39
ERCC4 Q92889 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3561938 0.81 KMT2A (0.57) KMT2AALDH1A1MAPTMEN1MAPK1
SCHEMBL15241368 0.81 AKR1B1 (0.55) KEAP1IDO1
SCHEMBL3620817 0.80 GABRA1 (0.35) CTBP2KEAP1NFE2L2
SCHEMBL3573836 0.79 ALDH1A1 (0.42) NPC1RAB9AKMT2AALDH1A1MEN1
SCHEMBL5824475 0.79 CTBP2 (0.50) CTBP2NPC1KEAP1NFE2L2KMT2A
SCHEMBL5824712 0.77 TDP1 (0.57) PKMKMT2AALDH1A1MAPTMEN1
SCHEMBL3562956 0.76 LMNA (0.50) KMT2AMAPTMEN1
SCHEMBL27567623 0.75 CTBP2 (0.57) CTBP2PKMNPC1RAB9AKCNJ5
SCHEMBL5824629 0.74 ALDH1A1 (0.50) NPC1RAB9AKMT2AALDH1A1MAPT
SCHEMBL3621881 0.74 BCAT2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135466-B2 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-11-14 US disclosed
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-21 US disclosed
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2004-07-08 US disclosed
EP-1243582-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA CTBP2 4747/4885PKM 2748/4885NPC1 4167/4885
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA CTBP2 4735/4885PKM 2429/4885NPC1 4076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.